Cargando…
Time to incorporate time in cost-effectiveness analysis
Cost-effectiveness analysis as a means to evaluate medical innovations has become well accepted in the UK and several other Western countries. An important assumption underlying this method is that costs and effects are constant over time. In reality, however, and especially in the short run, variat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343239/ https://www.ncbi.nlm.nih.gov/pubmed/22252307 http://dx.doi.org/10.1007/s10198-011-0374-3 |
_version_ | 1782231789835649024 |
---|---|
author | van de Wetering, Gijs Woertman, Willem H. Adang, Eddy M. |
author_facet | van de Wetering, Gijs Woertman, Willem H. Adang, Eddy M. |
author_sort | van de Wetering, Gijs |
collection | PubMed |
description | Cost-effectiveness analysis as a means to evaluate medical innovations has become well accepted in the UK and several other Western countries. An important assumption underlying this method is that costs and effects are constant over time. In reality, however, and especially in the short run, variations in costs and effects are likely to occur. These variations can lead to considerable deviations from the outcome of a conventional economic evaluation, which in turn may lead to serious implementation problems at a local level. Taking time into account explicitly in economic evaluations in health care may enhance their utility for both societal and local decision making, and may ultimately smooth the adoption of new and basically cost-effective health care technologies. |
format | Online Article Text |
id | pubmed-3343239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-33432392012-05-16 Time to incorporate time in cost-effectiveness analysis van de Wetering, Gijs Woertman, Willem H. Adang, Eddy M. Eur J Health Econ Editorial Cost-effectiveness analysis as a means to evaluate medical innovations has become well accepted in the UK and several other Western countries. An important assumption underlying this method is that costs and effects are constant over time. In reality, however, and especially in the short run, variations in costs and effects are likely to occur. These variations can lead to considerable deviations from the outcome of a conventional economic evaluation, which in turn may lead to serious implementation problems at a local level. Taking time into account explicitly in economic evaluations in health care may enhance their utility for both societal and local decision making, and may ultimately smooth the adoption of new and basically cost-effective health care technologies. Springer-Verlag 2012-01-18 2012 /pmc/articles/PMC3343239/ /pubmed/22252307 http://dx.doi.org/10.1007/s10198-011-0374-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Editorial van de Wetering, Gijs Woertman, Willem H. Adang, Eddy M. Time to incorporate time in cost-effectiveness analysis |
title | Time to incorporate time in cost-effectiveness analysis |
title_full | Time to incorporate time in cost-effectiveness analysis |
title_fullStr | Time to incorporate time in cost-effectiveness analysis |
title_full_unstemmed | Time to incorporate time in cost-effectiveness analysis |
title_short | Time to incorporate time in cost-effectiveness analysis |
title_sort | time to incorporate time in cost-effectiveness analysis |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343239/ https://www.ncbi.nlm.nih.gov/pubmed/22252307 http://dx.doi.org/10.1007/s10198-011-0374-3 |
work_keys_str_mv | AT vandeweteringgijs timetoincorporatetimeincosteffectivenessanalysis AT woertmanwillemh timetoincorporatetimeincosteffectivenessanalysis AT adangeddym timetoincorporatetimeincosteffectivenessanalysis |